Therapeutic Landscape in Mutational Triple Negative Breast Cancer

Molecular Cancer - United Kingdom
doi 10.1186/s12943-018-0850-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Differences in the Mutational Landscape of Triple-Negative Breast Cancer in African Americans and Caucasians

Breast Cancer Research and Treatment
Cancer ResearchOncology
2016English

Triple-Negative Breast Cancer

2018English

Therapeutic Advances and New Directions for Triple-Negative Breast Cancer

Breast Care
SurgeryOncology
2017English

Identification of Novel Therapeutic Targets for Triple-Negative Breast Cancer

2012English

Identification of New Candidate Therapeutic Target Genes in Triple-Negative Breast Cancer

Genes and Cancer
Cancer ResearchGenetics
2012English

Triple Negative Breast Cancer: Breast Cancer Research in Evolution

Breast Disease
MedicineCancer ResearchOncology
2011English

7. PD-L1 in Triple Negative Breast Cancer – Optimal Testing for Therapeutic Efficacy

Pathology
Forensic MedicinePathology
2020English

FZD7 in Triple Negative Breast Cancer Cells

2011English

Triple Negative Breast Cancer: Heterogenous Disease

REVIEWS IN ONCOLOGY
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy